| 2026-08-11 | Press release | Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update |
| 2026-08-05 | Press release | FENNEC PHARMACEUTICALS TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 11, 2026 |
| 2026-06-22 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) |
| 2026-06-15 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) |
| 2026-05-18 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) |
| 2026-05-14 | Press release | Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update |
| 2026-05-07 | Press release | FENNEC PHARMACEUTICALS TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 14, 2026 |
| 2026-04-07 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES Investigator-SPONSORED STUDY to be Conducted by University of Arizona Cancer Center |
| 2026-03-31 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) |
| 2026-03-24 | Press release | Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
| 2026-03-18 | Press release | Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 |
| 2026-03-16 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES SETTLEMENT AGREEMENT RESOLVING PEDMARK PATENT LITIGATION |
| 2026-03-04 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES CLINICAL RESEARCH COLLABORATION WITH TAMPA GENERAL HOSPITAL CANCER INSTITUTE |
| 2026-02-20 | Press release | FENNEC PHARMACEUTICALS PRESENTS REAL WORLD DATA SUPPORTING THE integration AND CLINICAL USE OF Pedmark® IN TREATING ADUL |
| 2025-12-09 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES Investigator-SPONSORED TRIAL to be Conducted by CITY OF HOPE IN Metastatic Testicular G |
| 2025-12-02 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE RESULTS FROM INVESTIGATOR-INITIATED CLINICAL STUDY OF PEDMARK® IN JAPA |
| 2025-11-25 | Press release | FENNEC PHARMACEUTICALS TO PARTICIPATE IN PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE |
| 2025-11-19 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES COMPLETION OF FULL DEBT REDEMPTION |
| 2025-11-17 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES CLOSING OF PRIVATE OFFERING OF COMMON SHARES IN CANADA |
| 2025-11-17 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES CLOSING OF OFFERING OF COMMON SHARES |
| 2025-11-13 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF COMMON SHARES |
| 2025-11-13 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES PRIVATE OFFERING OF COMMON SHARES IN CANADA |
| 2025-11-13 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES PRICING OF OFFERING OF COMMON SHARES |
| 2025-11-13 | Press release | FENNEC PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE |
| 2025-08-14 | Press release | FENNEC PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE |
| 2025-05-13 | Press release | FENNEC PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE |
| 2025-05-08 | Press release | FENNEC PHARMACEUTICALS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 13, 2025 |
| 2025-03-10 | Press release | FENNEC PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE |
| 2025-03-06 | Press release | FENNEC PHARMACEUTICALS TO REPORT FULL YEAR AND FOURTH QUARTER 2024 FINANCIAL RESULTS ON MARCH 10, 2025 |
| 2025-02-07 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES COMMERCIAL LAUNCH OF PEDMARQSI® IN GERMANY |
| 2024-12-20 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES PEDMARQSI POSITIVE RECOMMENDATION BY NICE FOR THE PREVENTION OF CISPLATIN-INDUCED HEARI |
| 2024-12-19 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES EARLY PARTIAL REPAYMENT OF ITS OUTSTANDING CONVERTIBLE DEBT FACILITY WITH PETRICHOR HEA |
| 2024-11-13 | Press release | FENNEC PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE |
| 2024-11-07 | Press release | FENNEC PHARMACEUTICALS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE |
| 2024-10-31 | Press release | Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 |
| 2024-10-28 | Press release | Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Nex |
| 2024-09-05 | Press release | FENNEC PHAMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES |
| 2024-08-13 | Press release | FENNEC PHARMACEUTICALS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE |
| 2024-08-05 | Press release | FENNEC PHARMACEUTICALS APPOINTS JEFFREY S. HACKMAN AS CHIEF EXECUTIVE OFFICER AND DIRECTOR |
| 2024-07-01 | Press release | FENNEC PHARMACEUTICALS ANNOUNCES MANAGEMENT CHANGE |